#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA891010	F	Antiviral activity against CVB2 in Vero 76 cells after 3 days by plaque reduction assay	Coxsackievirus B2	12	ALA1146386	organism-based format	Scientific Literature
2.	ALA922264	F	Antiviral activity against coxsackie B2 virus	Coxsackievirus B2	1	ALA1144007	organism-based format	Scientific Literature
3.	ALA994935	F	Antiviral activity against Coxsackievirus B2 in african green monkey Vero cells	Coxsackievirus B2	6	ALA1158184	organism-based format	Scientific Literature
4.	ALA984427	F	Antiviral activity against CVB2 infected in Vero76 cells assessed as reduction in virus plaque formation after 4 days by MTT assay	Coxsackievirus B2	85	ALA1144182	organism-based format	Scientific Literature
5.	ALA1049230	F	Antiviral activity against Coxsackie virus type B2 virus infected in african green monkey Vero-76 cells after 3 days by plaque reduction assay	Coxsackievirus B2	64	ALA1154067	organism-based format	Scientific Literature
6.	ALA1045044	F	Antiviral activity against Coxsackievirus B2 infected in african green monkey Vero cells assessed as reduction of virus plaque formation after 3 days	Coxsackievirus B2	6	ALA1154169	organism-based format	Scientific Literature
7.	ALA1037901	F	Antiviral activity against Coxsackie virus B2 infected in african green monkey Vero76 cells after 3 days by plaque reduction assay	Coxsackievirus B2	28	ALA1156068	organism-based format	Scientific Literature
8.	ALA1107216	F	Antiviral activity against Human coxsackievirus B2 Ohio-1 infected in african green monkey Vero cells after 3 days by plaque reduction assay	Coxsackievirus B2 (strain Ohio-1)	79	ALA1156237	organism-based format	Scientific Literature
9.	ALA1653252	F	Antiviral activity against Coxsackievirus B2 infected in human RD cells assessed as protection against virus-induced cytopathogenicity	Coxsackievirus B2	1	ALA1649506	organism-based format	Scientific Literature
10.	ALA1659319	F	Antiviral activity against Coxsackievirus serotype B2 infected in african green monkey BGMK cells assessed as inhibition of virus induced cytopathic effect after 18 to 24 hrs	Coxsackievirus B2	1	ALA1649227	organism-based format	Scientific Literature
11.	ALA2040339	F	Antiviral activity against Coxsackie virus type B2	Coxsackievirus B2	3	ALA2034874	organism-based format	Scientific Literature
12.	ALA3054843	F	Antiviral activity against Human coxsackievirus B2 infected African green monkey Vero76 cells assessed as reduction of virus-induced plaque reduction after 3 days by MTT assay	Coxsackievirus B2	8	ALA3046758	organism-based format	Scientific Literature
13.	ALA3073658	F	Antiviral activity against Human coxsackievirus B2 infected in African green monkey Vero 76 cells assessed as reduction in plaque number treated after viral infection measured after 3 days by plaque reduction assay	Coxsackievirus B2	23	ALA3046811	organism-based format	Scientific Literature
14.	ALA3738725	F	Antiviral activity against Human coxsackievirus B2	Coxsackievirus B2	1	ALA3734667	organism-based format	Scientific Literature
15.	ALA3782489	F	Antiviral activity against Human coxsackievirus B2 infected in african green monkey Vero cells after 24 to 36 hrs by MTS-based CPE reduction assay	Coxsackievirus B2	5	ALA3779764	organism-based format	Scientific Literature
16.	ALA3812813	F	Antiviral activity against CVB-2 infected in Vero 76 cells after 3 days by crystal violet staining based plaque reduction assay	Coxsackievirus B2	16	ALA3808296	organism-based format	Scientific Literature
17.	ALA5097593	F	Antiviral activity against Human Coxsackievirus B2 infected in African green monkey Vero cells assessed as reduction in virus-induced cytopathic effect incubated for 48 hrs by microscopic analysis	Coxsackievirus B2	1	ALA5096175	organism-based format	Scientific Literature